Letter From the JCTS Editor: A Year of Growth
Many of us attended the recent ACTS meeting that again took place in a virtual setting. The format worked out very well. I believe that we all learned new things from the many interesting and parallel sessions, and abstracts are available on the JCTS website. The meeting website turned out be very user-friendly and overall the meeting was an example of both how to do things better as well how to do better things. It would not be a surprise if some of these innovations have longevity and that similar approaches might be called for in future meetings. The meeting attracted some 1,300 participants which is a healthy indication of the growing interest in clinical and translational science.
JCTS is also looking back at a year of growth. I am very pleased to report that we had a >20% increase in the number of submissions during the year and this positive trend has continued. The published articles covered the full spectrum of translational science and we were happy to inaugurate the first of our thematic issues. To date, three such issues have been published with the themes of Dissemination and Implementation Science, Rural Health, and Data Science. As JCTS from January this year no longer is published in a classic issue format as articles are published right after acceptance, the question of how to distinguish a theme arises. Our website has a thematic issue identifier where all such issues are collected and participating papers listed, as a rule anchored by an introductory Editorial written by the guest editors for the theme. I invite you all to visit our web site and become familiar with this function. In the coming months we will publish several more thematic issues and we are interested in hearing suggestions for future themes as well.
As COVID-19 dominated much of the past year, it is not surprising that JCTS received a number of submissions related to the pandemic. To date, about 25% of our submissions from March 2020 have been related to COVID-19 and those submissions have been handled at a faster pace than other submissions given the urgency to spread information about the pandemic. It is interesting to note that some of these papers have received substantial interest and COVID 19-related papers are among the most downloaded JCTS papers during the year. As the attention to the journal and the many innovative papers published is on the increase, we warmly encourage the clinical and translational science community to consider JCTS for their research work. Our Editorial Board remains strongly committed to provide a high quality and expeditious service to the authors and we are grateful to the many colleagues who have contributed as reviewers. I feel very privileged to serve as the Editor-in-Chief and we continue to look forward to further improve the journal and to contribute to advance innovations and discoveries in translational science.
Lars Berglund, M.D., Ph.D., FAHA
Editor-in-Chief, Journal of Clinical and Translational Science (JCTS)
Translational Science 2021: Session Recordings Available
Translational Science 2021 took place virtually March 30 - April 2.
Session recordings from the event are available to attendees on the virtual event platform until 11:59 p.m. EDT on Sunday, May 2. Simply log in to view anything you missed or revisit a favorite session!
Stay tuned for information about Translational Science 2022 coming soon!
The ACTS Career Center is the premier resource for connecting those in the field of translational science with career opportunities. Visit today to find a wealth of resources to help achieve your career goals.
ACTS members receive a 50% discount on the site—use code ACTSMEMBER to save!
Journal of Clinical and Translational Science
The Data Science in Clinical and Translational Research thematic issue of the Journal of Clinical and Translational is now available online!
Visit our website for more information on the journal and how you can submit a manuscript. Submit your article today to be featured in future issues of JCTS!
Translational Science Today
Through her participation in COVID-19 research with the Duke Clinical and Translational Science Institute (CTSI), Connelia Houston learned about a new study in Kannapolis for people of African descent. The Duke APOL1 Study at the N.C. Research...